These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 31621813

  • 21. [Transthyretin Arg-83 mutation in vitreous amyloidosis].
    Chen L, Lü L, Zhang P, Li Y, Lin J.
    Yan Ke Xue Bao; 2008 Mar; 24(1):65-7. PubMed ID: 18709962
    [Abstract] [Full Text] [Related]

  • 22. [Bilateral vitreous opacities].
    Groh MJ, Schönherr U.
    Ophthalmologe; 2002 Mar; 99(3):204-5. PubMed ID: 11917805
    [No Abstract] [Full Text] [Related]

  • 23. Familial vitreous amyloidosis linked with factor V Leiden deficiency.
    Moortgat I, Van Ginderdeuren R, Van Calster J.
    Br J Ophthalmol; 2011 Dec; 95(12):1755, 1762. PubMed ID: 20805139
    [No Abstract] [Full Text] [Related]

  • 24. Elderly onset vitreous opacities as the initial manifestation in hereditary transthyretin (ATTR Val30Met) carries.
    Ishida K, Nishida T, Niimi Y, Suemori S, Mochizuki K, Kawakami H, Kimura A, Hirayama T.
    Ophthalmic Genet; 2017 Dec; 38(4):387-391. PubMed ID: 28085522
    [Abstract] [Full Text] [Related]

  • 25. Recurrent amyloid involvement in the virreous body after vitrectomy.
    Irvine AR, Char DH.
    Am J Ophthalmol; 1976 Nov; 82(5):705-8. PubMed ID: 998692
    [Abstract] [Full Text] [Related]

  • 26. Immunocytochemical demonstration of prealbumin in the vitreous in heredofamilial amyloidosis.
    Doft BH, Rubinow A, Cohen AS.
    Am J Ophthalmol; 1984 Mar; 97(3):296-300. PubMed ID: 6702967
    [Abstract] [Full Text] [Related]

  • 27. 25-gauge vitrectomy to treat ocular complications of familial amyloid polyneuropathy.
    Miyahara T, Ohta K, Yamamoto Y, Ueno A, Murata T.
    J Glaucoma; 2007 Jan; 16(1):169-70. PubMed ID: 17224769
    [Abstract] [Full Text] [Related]

  • 28. Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF.
    O'Hearn TM, Fawzi A, He S, Rao NA, Lim JI.
    Br J Ophthalmol; 2007 Dec; 91(12):1607-9. PubMed ID: 17522146
    [Abstract] [Full Text] [Related]

  • 29. Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy.
    Koga T, Ando E, Hirata A, Fukushima M, Kimura A, Ando Y, Negi A, Tanihara H.
    Am J Ophthalmol; 2003 Feb; 135(2):188-93. PubMed ID: 12566023
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Isolated vitreous amyloidosis].
    Vermuso L, Gueudry J, Sauvêtre G, Piton N, Guerrot AM, Sturtz F, Portmann A, Muraine M.
    J Fr Ophtalmol; 2017 Jan; 40(1):e7-e9. PubMed ID: 28065461
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.